EUVIMEDEUVIMED entdecken
Open Access

4-hydroxysesamin protects rat with right ventricular failure due to pulmonary hypertension by inhibiting JNK/p38 MAPK signaling

Lingnan Zhang, Xinshun Gu

Aging · 2024

DOI: 10.18632/aging.205808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Lingnan Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular, Affiliated Hospital of Hebei University, Baoding 071000, Hebei, China. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, p38 Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The specific mechanism of 4-hydroxysesamin (4-HS), a modification of Sesamin, on right ventricular failure due to pulmonary hypertension (PH) is ominous. By creating a rat model of PH in vivo and a model of pulmonary artery smooth muscle cell (PASMC) hypoxia and inflammation in vitro, the current work aimed to investigate in depth the molecular mechanism of the protective effect of 4-HS. In an in vitro model of hypoxia PASMC, changes in cell proliferation and inflammatory factors were detected after treatment with 4-HS, followed by changes in the JNK/p38 MAPK signaling pathway as detected by Western blot signaling pathway. The findings demonstrated that 4-HS was able to minimize PASMC cell death, block the JNK/p38 MAPK signaling pathway, and resist the promoting effect of hypoxia on PASMC cell proliferation. Following that, we found that 4-HS could both mitigate the right ventricular damage brought on by MCT and had a protective impact on rats Monocrotaline (MCT)-induced PH in in vivo investigations. The key finding of this study is that 4-HS may protect against PH by inhibiting the JNK/p38 MAPK signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, Pulmonaryp38 Mitogen-Activated Protein KinasesMAP Kinase Signaling SystemCell ProliferationAnimalsRatsMaleVentricular Dysfunction, RightMyocytes, Smooth MuscleLignansPulmonary ArteryHeart FailureRats, Sprague-DawleyMonocrotalineDisease Models, Animal

Stichwörter der Autor:innen

4-hydroxysesaminJNK/p38 MAPK signaling pathwaypulmonary hypertensionright ventricular failure

Substanzen

p38 Mitogen-Activated Protein KinasesLignansMonocrotaline

Autor:innen und Institutionen

  • Department of Cardiovascular, Affiliated Hospital of Hebei University, Baoding 071000, Hebei, China.
  • Department of Cardiovascular Sciences, Hebei Medical University, Shijiazhuang 050017, Hebei, China.
  • Department of Cardiovascular, The Second Hospital of Hebei Medicine University, Shijiazhuang 050000, Hebei, China.

Zitieren

APA

Zhang, L., & Gu, X. (2024). 4-hydroxysesamin protects rat with right ventricular failure due to pulmonary hypertension by inhibiting JNK/p38 MAPK signaling. Aging. https://doi.org/10.18632/aging.205808

Vancouver

Zhang L, Gu X. 4-hydroxysesamin protects rat with right ventricular failure due to pulmonary hypertension by inhibiting JNK/p38 MAPK signaling. Aging. 2024. doi:10.18632/aging.205808

BibTeX
@article{Zhang2024,
  author = {Zhang, Lingnan and Gu, Xinshun},
  title = {4-hydroxysesamin protects rat with right ventricular failure due to pulmonary hypertension by inhibiting JNK/p38 MAPK signaling},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205808}
}
Kostenlos starten →